1 / 31

Chapter 12

Chapter 12. Germ cell, stromal, and Other ovarian tumors. Germ cell tumors. Classification. Clinical profile. Relatively small proportion of all ovarian tumor(~20%) Occur in young women Recent developments of in chemotherapy -> prognosis 변화 Initial symptoms. Dysgerminoma.

Download Presentation

Chapter 12

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 12 Germ cell, stromal, and Other ovarian tumors

  2. Germ cell tumors • Classification

  3. Clinical profile • Relatively small proportion of all ovarian tumor(~20%) • Occur in young women • Recent developments of in chemotherapy -> prognosis 변화 • Initial symptoms

  4. Dysgerminoma • Uncommon tumor - 1-2% of primary ovarian neoplasms - 3-5% of ovarian malignancies • Occur at any age from infancy to old age : 7 Mo-70years - most cases occur in adolescence and early adulthood • Present at a relatively early stage - Ia 65-75% - Ib 10-15% - II+III 15% - IV 5%

  5. Stroma • - infiltrated with lymphocytes • - often contains granulomas similar to sarcoid • - occasionally, contains isolated gonadotropin producing syncytiotrophoblastic giant cells

  6. Gross finding - firm or flesh and cream colored or pale tan - both external and its cut surfaces may be lobulated

  7. Sexually abnormal females : a few dysgerminoma • - pure or mixed gonadal dysgenesis or testicular feminization. • - develops in a previously existing gonadoblastoma • Symptoms • - not distinctive • - similar to other solid ovarian neoplasms • - duration of Sx : usually short • - abdominal enlargement and presence of a mass in the lower abdomen(m/c) • One of the two most common malignant ovarian neoplasm in pregnancy • - serous cystadenoca. of low maliganant potential • - nonspecific finding • - relates to the age rather than to the pregnant states

  8. the opposite ovary may be involved with the tumor process - only germ cell tumor (10-15%) • Metastatic spread - lymphatic spread - hematogenous spread : occur later - any organ can affected : liver, lungs, bone

  9. Treatment • Historically, surgery followed by radiation • Recently, the use of multiple-agent chemotherapy • Chemotherapy • Recently appears to have become the treatment of choice • Success rate : as good as that of radiation • Preservation of fertility • used more frequently with significant success in patients who advanced disease • Optimal drug combination : not yet been determined • Doxorubicin and cyclophosphamide orcisplatin, vinblastin, and bleomycin (VBP) • Today, the treatment of choice after surgery in patients with advanced disease

  10. Conservative management - in the young woman with a unilateral encapsulated tumor - who desirous of future childbearing • Conservative surgery without radiation in stage Ia results

  11. In patient whom unilateral salpingo-oophoretomy is performed • careful inspection of the other ovary • rule out disseminated disease • assessment of the retroperitoneal lymph nodes • should be followed closely and have periodic examinations : 90% of recurrences appear in the first 2 years • most recurrences can be successfully eradicated by radiation therapy or chemotherapy • Several prognostic factors • Tumor size (>10cm) • Patient age : older than 40 years or younger than 20 years • Presence of other germ cell elements

  12. Report • Schwartz : 4 patients with metastasis to the contralateral ovary and preservation of ovary with subsequent CTx • All patients were alive and had no disease 14-56 Mo after diagnosis • De palo …. : 56 patients who had pure dysgerminomas - 5 year relapse-free survival rates • Stage Ia, Ib, Ic : 91% • Stage III retorperitoneal disease :74% • Stage III peritoneal disease : 24% • peritoneal involvement of any kind was associated a poor prognosis

  13. Recurrences • Should be treated aggressively with reexploration and tumor reduction • Removed tissue : examined carefully for evidence of germ cell elements other than dysgerminoma • Tx of Dysgerminoma associated with gonadoblastoma • Radical because of the frequent occurrence of bilateral tumors and the absence of normal gonadal function • Investigation of the genotypes and karyotypes of all patients • Preserve the uterus : IVF can be utilized • Tx of dysgerminoma contain small areas of more malignant histology(embryonal ca or EST) • The prognosis and therapy are determined by the more malignant germ cell elements

  14. Endodermal Sinus Tumor (Yolk Sac Tumor) • second most common form of malignant germ cell tumor • 22% of germ cell lesions • ¾ of the patients : combination of abdominal pain and abdominal or pelvic mass • Median age : 19years • Sx • Acute pain : torsion • Almost always unilateral • Size : 10-30 cm

  15. Cut surface : gray yellow with areas of hemorrhage and cystic gelatinous changes • Consist of • scattered tubules or spaces lined by single layers of flattened cuboidal cells • loose reticular stroma • Numerous scattered para-amnosalicylic-positive globules • Characteristic invaginated papillary structure with a central blood vessel

  16. Highly malignant • Metastasize early and invade the surrounding structures • Intraabdominal spread : extensive involvement of abdominal structures with tumor deposits • Metastases also occur via the lymphatic system • AFP level are often elevation • Characterized by extreme rapid growth and extensive intra-abdominal spread

  17. prognosis • Historically : Unfavorable, died within 12-18MO of diagnosis Treatment • In the past : frustrating • Kurman and Norris : no logn-term survirors in 17 pts with stage I tumor who were receiving adjuvant RTx and single alkylating agents, dactinomycin or MTX • Gallion : review the literature in 1979 - only 27% of 96 patients with stage I EST were alive at 2 years • not sensitive to radiation therapy • Optimal surgical extirpation of the disease : advocated

  18. In later years : optimistic reports of sustained remission in some pts treated by surgery and multiple agent chemotherapy

  19. GOG : VAC, pure EST 31 pts • 15(48%) failed, including 11 of 24(46%) who had complete resection • GOG : VAC, mixed germ cell tumors containing EST 15 pts • 8(53%) failed • GOG : VAC, stage I-III completely resected EST 48 pts • 35(73%) pts were free of disease with a median follow time of 4 years • Gershenson and associates : VAC, pure EST • 18 of 26(69%) pts were free • Gallion and associates : VAC, stage I disease • 17 of 25(68%) pts were alive and well 2 years or more after • Sessa… : VBP, pure EST • 13 pts, unilateral oophorectomy(12) • All received VBP and are alive at 20 months to 6 years

  20. Schwartz …: used VAC for stage I disease but prefer VBP for stage II-IV • 12 of 15 pts are alive and have no evidence of disease. • treat at least one course beyond a normal AFP titer • one recurrence was treated successfully with BEP • GOG : evaluated VBP in stage III and IV • 16 of 29(55%) ESTs were long-term disease-free survivor • Induced a substantial number of durable complete responses, even in Pts with prior CTx • Toxicity was significant • Smith….: disease were resistant to MAC and VBP • complete remission with VP-16 and cisplatin contained regimen • Williams • In disseminated germ cell tumors, BEP was more effective and had less neuromuscular toxicity than had VBP

  21. Williams : reported the GOG experience • 93 patients who were given BEP postoperatively in an adjuvant setting for malignant germ cell cancers of the ovary • Immature teratomas(42), EST(25), mixed germ cell tumors(24) • 91 of 93 had no evidence of disease after three course of BEP with median follow-up of 39 months • Dimopoulos • 40 pts with nondysgerminomatous tumor were treated BEP or PVB • Median follow-up of 39 months • 5 pts developed progressive disease and died • Fujita • 41 pts with EST, either pure or mixed • More aggressive surgery did not increase survival • Survival was similar whether VAC or PBV • All stage I pts given either VAC or PBV following surgery survived without evidence of recurrence

  22. Serum AFP • Useful diagnostic tool in patients who have EST • Ideal tumor marker • Can be useful when monitoring the results of therapy and for detecting metastasis and recurrences after therapy • Levels of hCG and its b subunit • Normal

  23. Embryonal carcinoma • One of the most malignant cancer in the ovary • Only 4% of the malignant ovarian germ cell tumors • A mean age : 15 years • More than half of the pts have hormonal abnormalities • Precocious puberty, irregular uterine bleeding, amenorrhea, or hirsutism

  24. Consist of large primitive cells with occasional papillary or gland-like formations(f12-7) • The cell have eosinophilic cytoplasm with distinct borders and round nuclei with prominent nucleoli • Numerous mitotic figures, many atypical multinucleated giant cells

  25. EST vs Embryonal ca • Contain hCG, syncytiotrophoblast-like cells and AFP in the large primitive cells • Kurman and Norris • Actual survival rate of 30% for the entire group • Stage I tumor, survival rate was 50% • With modern therapy, survival rates should greatly improved

  26. Optimal therapy • Not yet established • Probably similar to that for EST • VAC • Definitely active in this disease • Not appear to be as reliable for advanced cases as VBP • VBP • Can be used at that point in the hope of salvage • Total number of courses of VAC therapy • Really not known • GOG : evaluated the effectiveness of the VBP in stage III, IV, recurrent malignant germ cell tumors • Overall progression-free interval at 24 months : 55% • hCG and AFP : progression monitor

  27. Polyembryoma • Rare ovarian germ cell neoplasm • In most cases, associated with other neoplastic germ cell elements(immature teratoma) • Highly malignant germ cell neoplasm • Invasion of adjacent structures and organs • Not sensitive to RTx • Response to CTx : unknown

  28. Choriocarcinoma • Rare • Highly malignant tumor • May be associated with sexual precocity • Arise in one of three ways • Primary gestational choriocarcinoma associated with ovarian pregnancy • Metastatic choriocarcinoma form a primary gestational choriocarinoma arising in other parts • A germ cell tumor differentiating in the direction of trophoblastic structures • In the most cases, the tumor is admixed with other neoplastic germ cell elments • Occurs in children and young adults

  29. Secrete hCG • Precocious puberty • Mammary development, growth of pubic and axillary hair, and uterine bleeding • Adult patients : signs of ectopic pregnancies • Associated with an increased production of hCG • Estimation of urinary or plasma hCG levels • useful diagnostic test • Prognosis • Historically : unfavorable • Modern CTx regimen : effective • Creasman….: MAC • Prolonged remissions • Combination CTx using MTX or dactinomycin and alkylating agent

  30. Mixed Germ Cell Tumors • Contain at least two malignant germ cell elements • Dysgerminoma(m/c, 65-80%) • MD anderson Hospital • 9 pts(surgery alone), 6 pts(RTx) : all recurrences • Of 17 pts (VAC) : 9 were placed into remission • 5 pts (VBP after surgery) : 4 are alive and well • 20 pts are alive and well • 14 pts who had stage I disease and were treated with combination CTx after surgery : 11(79%) survived • Creasman… : treated 5 pts stage I lesion, MAC • 3 pts also received RTx • All 5 were long-term survivors • GOG • 10 completely resected tumor, VAC : 7 are long-term survivors • 5 incompletely resected disease, VAC : 4 recurrence

  31. Schwartz • 8 pts, VAC • 7 long-term survivors

More Related